OSX Stock Overview
Osteopore Limited engages in the design, development, and marketing of bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Osteopore Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.34 |
| 52 Week High | AU$2.17 |
| 52 Week Low | AU$0.053 |
| Beta | 0.45 |
| 1 Month Change | 423.08% |
| 3 Month Change | -33.33% |
| 1 Year Change | -71.67% |
| 3 Year Change | -95.68% |
| 5 Year Change | n/a |
| Change since IPO | -96.87% |
Recent News & Updates
Shareholder Returns
| OSX | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 183.3% | 0.5% | 0.9% |
| 1Y | -71.7% | 13.1% | 5.7% |
Return vs Industry: OSX underperformed the Australian Medical Equipment industry which returned 13.1% over the past year.
Return vs Market: OSX underperformed the Australian Market which returned 5.7% over the past year.
Price Volatility
| OSX volatility | |
|---|---|
| OSX Average Weekly Movement | 146.2% |
| Medical Equipment Industry Average Movement | 10.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: OSX's share price has been volatile over the past 3 months.
Volatility Over Time: OSX's weekly volatility has increased from 65% to 146% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Yujing Lim | www.osteopore.com |
Osteopore Limited engages in the design, development, and marketing of bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects.
Osteopore Limited Fundamentals Summary
| OSX fundamental statistics | |
|---|---|
| Market cap | AU$3.51m |
| Earnings (TTM) | -AU$4.87m |
| Revenue (TTM) | AU$2.22m |
1.6x
P/S Ratio-0.7x
P/E RatioIs OSX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSX income statement (TTM) | |
|---|---|
| Revenue | AU$2.22m |
| Cost of Revenue | AU$581.51k |
| Gross Profit | AU$1.64m |
| Other Expenses | AU$6.51m |
| Earnings | -AU$4.87m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.47 |
| Gross Margin | 73.78% |
| Net Profit Margin | -219.72% |
| Debt/Equity Ratio | 246.0% |
How did OSX perform over the long term?
See historical performance and comparison